Kenji Katsumata

Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212)

Shin Fujita, Junki Mizusawa, Yukihide Kanemitsu et al. · Annals of Surgery · 2017 · 446 citations · Full text

Medicine, Oncology, Surgery +16

Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical Trial

Yukihide Kanemitsu, Kohei Shitara, Junki Mizusawa et al. · Journal of Clinical Oncology · 2021 · 198 citations · Full text

Medicine, Oncology, Surgery +12

Clinical Impact of Neoadjuvant Chemotherapy and Chemoradiotherapy in Borderline Resectable Pancreatic Cancer: Analysis of 884 Patients at Facilities Specializing in Pancreatic Surgery

Yuichi Nagakawa, Yatsuka Sahara, Yuichi Hosokawa et al. · Annals of Surgical Oncology · 2019 · 120 citations

Medicine, Oncology, Surgery +15

Clinicopathological Features and Prognostic Factors of Adenocarcinoma of the Esophagogastric Junction According to Siewert Classification: Experiences at a Single Institution in Japan

Yuichi Hosokawa, Takahiro Kinoshita, Masaru Konishi et al. · Annals of Surgical Oncology · 2011 · 119 citations

Medicine, Oncology, Pathology +14

Neutrophil-to-lymphocyte ratio is a prognostic factor for colon cancer: a propensity score analysis

Junichi Mazaki, Kenji Katsumata, Kenta Kasahara et al. · BMC Cancer · 2020 · 101 citations · Full text

Medicine, Immunology, Oncology +14